Tamarugatam Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 43.03%
- Profit Growth 114.67%
- Ebitda -60.35%
- Net Worth 18.21%
- Total Assets 23.21%
About Tamarugatam Pharmaceuticals
Tamarugatam Pharmaceuticals Private Limited (TPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 February 1998 and has a history of 26 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pondavakkam Vijayalakshmi, Pondavakkam Ayyappan, Pondavakkam Jeeva, and One other member serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909TN1998PTC039979
-
Company No.
039979
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Feb 1998
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Tamarugatam Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pondavakkam Vijayalakshmi
|
Director | 17-Mar-2010 | Current |
|
Pondavakkam Ayyappan
|
Director | 04-Feb-2019 | Current |
|
Pondavakkam Jeeva
|
Director | 04-Feb-2019 | Current |
|
Pondavakkam Ananthakrishnan
|
Director | 25-Feb-1998 | Current |
Financial Performance of Tamarugatam Pharmaceuticals.
Tamarugatam Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.03% increase. The company also saw a substantial improvement in profitability, with a 114.67% increase in profit. The company's net worth Soared by an impressive increase of 18.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tamarugatam Pharmaceuticals?
In 2019, Tamarugatam Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tamarugatam Pharmaceuticals?
Unlock and access historical data on people associated with Tamarugatam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tamarugatam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tamarugatam Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
